Skip to main content

Market Overview

Theravance Biopharma (NASDAQ: TBPH)

18.48 -0.06 (-0.32%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:




Q4 2021
After-Hours
EPS:
REV:




Q3 2021
After-Hours
EPS:
REV:
-1.16
18.257M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-1.14
19.862M
-1.05
17.27M
-1.24
14.257M
-18.1%
-17.45%
Q4 2020
After-Hours
EPS:
REV:
-1.17
29.499M
-1.02
20.85M
-0.92
18.73M
9.8%
-10.17%
Q3 2020
After-Hours
EPS:
REV:
-1.05
12.427M
-0.97
18.58M
-1.16
18.257M
-19.59%
-1.74%
Q2 2020
After-Hours
EPS:
REV:
-0.72
26.15M
0.98
19.64M
-1.00
15.008M
-202.04%
-23.58%
Q1 2020
After-Hours
EPS:
REV:
-1.32
5.338M
-1.07
18.13M
-1.14
19.862M
-6.54%
9.55%
Q4 2019
After-Hours
EPS:
REV:
-0.92
15.737M
-1.13
16.84M
-1.17
29.499M
-3.54%
75.17%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!